Loading...

Cannara Biotech Inc.

LOVFF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.30
$0.02(1.56%)
U.S. Market opens in 7h 39m

Cannara Biotech Inc. (LOVFF) Stock Overview

Explore Cannara Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap128.4M
P/E Ratio16.79
EPS (TTM)$0.08
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$1.31
3 Months$1.38
1 Year Target$1.95

LOVFF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cannara Biotech Inc. (LOVFF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.79 and a market capitalization of 128.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.56%
5-Day Change
0.78%
1-Month Change
-1.52%
3-Month Change
-5.11%
6-Month Change
9.24%
Year-to-Date (YTD) Change
2.36%
1-Year Change
28.71%
3-Year Change
163.91%
5-Year Change
6.56%
All-Time (Max) Change
-27.37%

Contact Information

https://cannara.ca
514-543-4200
333 Decarie Blvd., Saint-Laurent, QC, H4N 3M9

Company Facts

461 Employees
IPO DateJan 18, 2019
CountryCA
Actively Trading

Frequently Asked Questions